Question 1

Does AllianceBernstein own SAVA stock?

Accepted Answer

No. AllianceBernstein exited its SAVA (Filana Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 37,000 shares worth $55,500.

Question 2

How many shares of SAVA does AllianceBernstein own?

Accepted Answer

None since Q2 2025, when AllianceBernstein exited the position. Its Q1 2025 13F listed 37,000 shares worth $55,500.

Question 3

What is AllianceBernstein's SAVA position worth?

Accepted Answer

AllianceBernstein's SAVA position was worth $55,500 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is AllianceBernstein buying or selling SAVA?

Accepted Answer

In Q2 2025, AllianceBernstein exited its entire SAVA position.

Question 5

When did AllianceBernstein first buy SAVA?

Accepted Answer

AllianceBernstein first reported SAVA in its Q2 2020 13F and listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$1.81
2025-Q1	Decreased	37,000	-3.1%	$55,500	0.0%	$1.50
2024-Q4	Unchanged	38,200	0.0%	$90,152	0.0%	$2.36
2024-Q3	Unchanged	38,200	0.0%	$1.1M	0.0%	$29.43